Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Nanobiotix
  6. Financials
    NANO   FR0011341205

NANOBIOTIX

(NANO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 228185475241241-
Enterprise Value (EV)1 213194405167200236
P/E ratio -7,51x-3,52x-9,86x-4,58x-4,34x-4,19x
Yield ------
Capitalization / Revenue 65,6x72,8x189x105x115x127x
EV / Revenue 61,1x76,5x161x72,7x95,1x124x
EV / EBITDA -7,22x-4,32x-11,7x-4,08x-3,78x-4,28x
Price to Book 16,0x-97,3x----
Nbr of stocks (in thousands) 19 61422 34734 42734 81134 811-
Reference price (EUR) 11,68,2813,86,936,936,93
Announcement Date 03/15/201903/17/202003/17/2021---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 3,482,542,512,302,101,90
EBITDA1 -29,4-45,0-34,7-40,9-52,8-55,1
Operating profit (EBIT)1 -30,1-46,8-36,4-42,6-54,4-56,7
Operating Margin -864%-1 841%-1 450%-1 850%-2 589%-2 984%
Pre-Tax Profit (EBT)1 -30,3-50,9-33,6-55,9-58,8-68,8
Net income1 -30,3-50,9-33,6-68,1-101-105
Net margin -872%-2 004%-1 337%-2 961%-4 794%-5 505%
EPS2 -1,55-2,35-1,40-1,51-1,60-1,65
Dividend per Share2 ------
Announcement Date 03/15/201903/17/202003/17/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2019 S1 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2
Net sales1 1,820,721,451,061,321,00
EBITDA ------
Operating profit (EBIT)1 -20,5-26,3-18,4-18,0-29,8-24,6
Operating Margin -1 123%-3 665%-1 270%-1 696%-2 258%-2 460%
Pre-Tax Profit (EBT)1 -23,9-27,0-20,6-13,0-30,4-25,5
Net income1 -23,9-27,0-20,6-13,0-30,4-25,5
Net margin -1 312%-3 760%-1 421%-1 223%-2 306%-2 550%
EPS2 -1,15-1,20-0,91-0,49-0,88-0,70
Dividend per Share ------
Announcement Date 09/04/201903/17/202009/04/202003/17/202109/08/2021-
1 EUR in Million
2 EUR
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 -9,43----
Net Cash position1 15,7-70,274,141,65,48
Leverage (Debt / EBITDA) 0,53x-0,21x2,02x1,81x0,79x0,10x
Free Cash Flow1 -26,4-42,3-27,6-27,1-28,6-
ROE (Net Profit / Equities) -104%-826%-98,0%-107%-180%-237%
Shareholders' equity1 29,16,1734,363,455,844,1
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share 0,73-0,09----
Cash Flow per Share2 -1,32-1,90-1,13-0,83-1,45-1,35
Capex1 0,421,090,101,051,051,05
Capex / Sales 12,0%42,9%3,82%45,7%50,0%55,3%
Announcement Date 03/15/201903/17/202003/17/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Key data
Capitalization (EUR) 241 238 975
Capitalization (USD) 269 269 980
Net sales (EUR) 2 512 000
Net sales (USD) 2 800 126
Number of employees 98
Sales / Employee (EUR) 25 633
Sales / Employee (USD) 28 573
Free-Float 94,5%
Free-Float capitalization (EUR) 227 903 244
Free-Float capitalization (USD) 254 384 691
Avg. Exchange 20 sessions (EUR) 1 005 598
Avg. Exchange 20 sessions (USD) 1 120 940
Average Daily Capital Traded 0,42%
EPS & Dividend